News

Manhattan Bridge Capital's Q1 Performance Highlights and Financials

Manhattan Bridge Capital's Q1 Performance Highlights and Financials

Understanding Manhattan Bridge Capital's Q1 Financial Results

As we dive into the financials for Manhattan Bridge Capital, Inc. (NASDAQ: LOAN) for the first quarter of 2025, the figures provide insights into the company's performance and strategic positioning amid evolving market conditions.

Income and Revenue Analysis

During this quarter, Manhattan Bridge Capital reported a net income of approximately $1.37 million, translating into a basic earnings per share of $0.12 based on about 11.4 million shares outstanding. This marks a decrease from last year’s reported earnings of $1.48 million or $0.13 per share for the same period. A closer examination of the underlying causes shows a $103,000 drop in income, primarily attributed to declining interest receipts from loans, although this was somewhat balanced by reduced interest expenses.

Revenue Comparison Over the Year

The total revenue for the company in Q1 2025 was approximately $2.27 million, compared to $2.57 million in Q1 2024. This decrease of $299,000 can largely be traced back to diminished interest income resulting from fewer loans receivable. Interestingly, while revenue from secured commercial loan interests fell to about $1.83 million from $2.14 million, the origination fees engaged in generating new loans showed a marginal change, with $440,000 sourced this quarter against $431,000 the year prior.

Market Outlook and Business Strategy

Assaf Ran, the Chairman and CEO, shared candid thoughts regarding current market sentiments. He remarked on the initial optimism shared among real estate investors at the start of the year. However, ongoing delays in expected interest rate reductions and an unpredictable global economic environment have since raised concerns regarding a rapid market recovery. Despite these challenges, Ran emphasized the company's advantage stemming from its low leverage and robust borrower relationships, suggesting a positive outlook for navigating potential risks ahead.

Company Overview & Operations

Manhattan Bridge Capital specializes in providing short-term, non-banking loans, often referred to as 'hard money' loans for real estate investors. These loans facilitate various property-related ventures, including acquisitions, renovations, and general improvements, predominantly within the metropolitan area. This operational model allows the company to leverage its expertise and network effectively, serving a diverse range of real estate needs.

Shareholders' Equity Insights

As of the end of March 2025, total shareholders' equity stood at approximately $43.33 million, indicating a steady foundation for future growth and investment opportunities. This equity is critical as the company continues to expand its lending portfolio and optimize its financial positioning.

Conclusion

In summary, Manhattan Bridge Capital's first quarter performance in 2025 reflects distinct challenges alongside notable revenue sources from secured loans. The company's proactive management underlines confidence in its strategy to maintain stability and growth in a competitive lending landscape.

Frequently Asked Questions

What were the key financial figures for Q1 2025?

Manhattan Bridge Capital reported a net income of approximately $1.37 million with total revenues of around $2.27 million.

How did the company's earnings per share change?

The earnings per share decreased to $0.12 in Q1 2025, down from $0.13 in the previous year.

What is the main source of revenue for the company?

The primary revenue source is interest income from secured commercial loans offered to real estate investors.

What challenges is Manhattan Bridge Capital facing in 2025?

The company faces challenges related to potential market recovery due to delayed interest rate reductions and overall global economic uncertainty.

What strategy is the company adopting to ensure profitability?

The company emphasizes low leverage and strong relationships with borrowers to mitigate risks and navigate the prevailing market challenges.

About The Author

About Investors Hangout

Investors Hangout is a leading online stock forum for financial discussion and learning, offering a wide range of free tools and resources. It draws in traders of all levels, who exchange market knowledge, investigate trading tactics, and keep an eye on industry developments in real time. Featuring financial articles, stock message boards, quotes, charts, company profiles, and live news updates. Through cooperative learning and a wealth of informational resources, it helps users from novices creating their first portfolios to experts honing their techniques. Join Investors Hangout today: https://investorshangout.com/

The content of this article is based on factual, publicly available information and does not represent legal, financial, or investment advice. Investors Hangout does not offer financial advice, and the author is not a licensed financial advisor. Consult a qualified advisor before making any financial or investment decisions based on this article. This article should not be considered advice to purchase, sell, or hold any securities or other investments. If any of the material provided here is inaccurate, please contact us for corrections.

Top 10 Most Recent News Articles

Better Home & Finance Tumbles: Legal Woes and Losses Mount

Updated Category News Views 0

Better Home & Finance's Financial Freefall The rollercoaster of stock markets sees plenty of ups and downs, but when you tack on a securities class action, it’s more like getting stuck on a loop. That’s exactly where Better Home & Finance (NASDAQ: BETR) finds itself after the wheels came off in their Q1 2026 report. A gut-wrenching 75% jump in their net loss tells you...

Continue Reading
Cytrellis Boosts Aesthetics Training With Miami Partnership

Updated Category News Views 22

Cytrellis Partners with University of Miami The announcement from Cytrellis Biosystems is drawing some attention. The company's jumped into a new partnership with the University of Miami School of Nursing and Health Studies, looking to jazz up their Aesthetic Medicine Certificate Program. The kicker here is the introduction of Cytrellis' ellacor® system, a fancy bit of...

Continue Reading
Skechers Faces Shareholder Lawsuit: Must Act by Dec 21

Updated Category News Views 69

Skechers Shareholders Stirring Over Lawsuit A fresh wave of legal antics is crashing at the shores of Skechers U.S.A., Inc. (NYSE: SKX) as frustrated shareholders mobilize against the footwear juggernaut. We're talking about a class action lawsuit here, folks, aimed at shaking down some clarity—or maybe just some cold, hard cash—from this bruiser over some sketchy...

Continue Reading
CapCut's AI Growth Combines Video, Image, and Music Tools

Updated Category News Views 114

CapCut's Recognition in the Creative AI Space The shift towards comprehensive creative platforms is taking the tech world by storm, and CapCut's latest nod from Software Experts is turning heads in 2026 with its ambitious integration. Touted for its versatility, CapCut serves creative projects that need an amalgamation of video, image, and audio elements. Tackling the...

Continue Reading
Cerebras Faces Durability Allegations: Investor Alert

Updated Category News Views 57

Cracks in Cerebras' Processor Promises? When you dance with high-stakes tech stocks, sometimes you end up stepping on a few toes. This seems to ring true as Cerebras Systems (CBRS) dances its way into hot water. Allegations from Culper Research suggest their fancy AI processors, which are supposed to be the poster children of reliability, might bow out early. Digging...

Continue Reading
Orbis International to Boost Global Eye Health Efforts

Updated Category News Views 0

Pledge for Vision In a world where a staggering number of folks wrestle with avoidable vision issues, Orbis International is stepping up to the plate with ambitions that feel as bold as they are necessary. Orbis is pouring a significant $32 million into its mission to beef up eye health systems, train a small army of professionals, and apply AI in eye care. Their big bet...

Continue Reading
Phrontline's TJ101 Gains Momentum in Cancer Clinical Trials

Updated Category News Views 119

Encouraging Signs from Phrontline's TJ101 ADC Trials In the high-stakes race to outsmart cancer, Phrontline Biopharma is banking on TJ101, their star investigational bispecific antibody-drug conjugate (ADC). The recent results shared at the ESMO Congress 2026 are stirring up quite a bit of chatter. Urothelial Carcinoma and Beyond Now, picture this: six of eight evaluable...

Continue Reading
Green Methanol: A $20.11B Market by 2032 Excites

Updated Category News Views 9

The Green Methanol Boom Folks, the money's about to get greener—greener methanol, that is. We’re talking about a market that’s set to explode from a humble $3.46 billion in 2026 to a jaw-dropping $20.11 billion by 2032. With a hefty CAGR of 34.1%, it seems like investors might want to buckle up for a bullish ride in this eco-friendly venture. Why Green Methanol?...

Continue Reading
Epicurean Expeditions Mix Food Joy with Ocean Luxury

Updated Category News Views 50

Atlas Expands Culinary Cruise Horizons in 2027 Now here's a twist for you—cuisine meets cruise in a hefty blend of sail, chew, and swirl. Atlas Ocean Voyages is practically throwing a gourmet party on water with their 2027 Epicurean Expeditions. They're unfurling the sails alongside chef heavyweights like Crista Luedtke and wine maestro Anthony Giglio. Imagine a cruise...

Continue Reading
Gate's Strong Q3: Sales Growth & Rising Margins

Updated Category News Views 39

Solid Performance Boosts Confidence Gates Industrial came out swinging with their third-quarter results for 2026, showing some financial prowess that would make even the skeptics raise an eyebrow. Net sales climbed to a hefty $903.6 million, advancing 5.6% from the same time last year. It's not just smoke—core sales jumped 5.5%, signaling they're doing a bit more than...

Continue Reading

Top 5 Most Recently Viewed Articles

Are PEPE, WIF, and POPCAT Set to Eclipse Shiba Inu in 2024?

Updated Category News Views 94

Meme Coins on the Rise: Will PEPE, WIF, and POPCAT Lead the Charge? Several analysts are suggesting that the emerging meme coins PEPE, WIF, and POPCAT could be primed for exceptional growth and outperformance against well-known competitors like Shiba Inu and Dogecoin. With mounting excitement surrounding these digital assets, traders are closely analyzing price movements...

Continue Reading
AppLovin's E-commerce Growth Signals Potential Q4 Upside

Updated Category News Views 226

AppLovin's Recent Momentum in E-Commerce AppLovin Corp (NASDAQ: APP) is experiencing notable momentum as it expands its e-commerce capabilities. This growth is primarily attributed to a significant increase in the number of merchants adopting its Axon advertising technology, which has raised expectations for a potential upside in the fourth quarter. Recent analysis...

Continue Reading
Exploring the Surge in Functional Gummies Market Growth

Updated Category News Views 252

Exploring the Rise of the Functional Gummies Market The functional gummies market is set to witness significant growth as it responds to evolving consumer demands for health-focused products. This market capitalizes on the intersection of nutrition, wellness, and enjoyment, providing essential nutrients in a format that appeals to a wide audience. The transition towards...

Continue Reading
Cavvy Energy Exceeds Expectations with Robust Q3 Results

Updated Category News Views 168

Cavvy Energy Reports Strong Q3 2025 Financial Performance CALGARY, Alberta — Cavvy Energy Ltd. (TSX: CVVY) has released its financial and operational results for the third quarter of 2025, showcasing impressive growth and resilience amidst market challenges. In this quarter, the company reported a production rate of 23,956 barrels of oil equivalent per day (boe/d) and a...

Continue Reading
AI Privacy Risks When Sharing Financial Documents

Updated Category Personal Finance Views 248

AI tools have made life easier in so many ways that one sometimes overlooks their risks. For financial analysis and guidance, an empathetic and supportive AI chatbot may feel like the perfect ally. But that illusion can be damaged if you find business or personal finance information exposed or misused. If you currently use AI tools for financial analysis or assessments,...

Continue Reading